Electronic supplementary material ESM Downloadable slide (download PPTX (PPTX 145 kb) Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
When can I expect to feel less hungry after starting semaglutide GLP-1
Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight (STEP 3)
Diarrhea: Antibiotics can disrupt the healthy bacteria in your gut, leading to loose stools
The peptide modulates metabolic pathways involved in MASLD pathogenesis, including reducing inflammatory cytokines that contribute to steatohepatitis progression
Baseline Patient Characteristics Patient characteristics captured from the administrative claims data during the 12-month baseline period included age, gender, insurance type, geographic region, Charlson comorbidity index [21, 22] and commonly diagnosed comorbid conditions operationalized by the Agency for Healthcare Research and Quality [23]
